Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants among Unselected Patients with Prostate Cancer: the PROCLAIM Trial. Neal Shore , Mukaram Gazi , Christopher Pieczonka , Sean Heron , Rishi Modh , David Cahn , Laurence H. Belkoff , Aaron Berger , Brian Mazzarella , Joseph Veys , Charles Idom , David Morris , Gautam Jayram , Alexander Engelman , Raviender Bukkapatnam , Paul Dato , Richard Bevan-Thomas , Robert Cornell , David R. Wise , Mary Kay Hardwick , Ryan D. Hernandez , Susan Rojahn , Paige Layman , Kathryn E. Hatchell , Brandie Heald , Robert L. Nussbaum , Sarah M. Nielsen , Edward D. Esplin European Urology Oncology（2023）
关键词
Prostate cancer, Genetic testing, Hereditary cancer risk, Precision medicine, Professional guidelines, Racial disparities
AI 理解论文
溯源树
样例
